765
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes

, , , &
Pages 507-516 | Received 07 May 2014, Accepted 30 Jul 2014, Published online: 28 Aug 2014

References

  • Agency for Health Care Administration. (2014). Nursing home guide. Retrieved from http://www.floridahealthfinder.gov/facilitylocator/ListFacilities.aspx
  • Becker, M., & Mehra, S. (2005). Serious mental illness in Florida nursing homes: A study of resident, facility, cost and quality of care characteristics (Report to Agency for Health Care Administration). Tampa, FL: University of South Florida.
  • Berg, B.L., & Lune, H. (2012). Qualitative research methods for social sciences. Upper Saddle River, NJ: Pearson Education.
  • Bonner, A. (2013). Improving dementia care and reducing unnecessary use of antipsychotic medication in nursing homes. Retrieved from https://doh.sd.gov/news/documents/cms_dementia_care.pdf.
  • Briesacher, B.A., Limcangco, M., & Simoni-Wastila, L. (2005). The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine, 165(11), 1280–1285. doi:10.1001/archinte.165.11.1280
  • Burgio, L.D., Stevens, A., Burgio, K.L., Roth, D.L., Paul, P., & Gerstle, J. (2002). Teaching and maintaining behavior management skills in the nursing home. Gerontologist, 42(4), 487–196.
  • Camp, C.J., Cohen-Mansfield, J., & Capezuti, E.A. (2002). Use of nonpharmacological interventions among nursing home residents with dementia. Psychiatric Services, 53(11), 1397–1401.
  • Carson, S., McDonagh, M.S., & Peterson, K. (2006). A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia. Journal of the American Geriatrics Society, 54, 354–361. doi:10.1111/j.1532-5415.2005.00566.x
  • Caspar, S., & O’Rourke, N. (2008). The influence of care provider access to structural empowerment on individual care in long-term-care facilities. Journals of Gerontology: Social Sciences, 63B(4), S225–S265.
  • Castle, N.G., & Engberg, J. (2005). Staff turnover and quality of care in nursing homes. Medical Care, 43(6), 616–626.
  • Castle, N.G., & Ferguson, J.C. (2010). What is nursing home quality and how is it measured? The Gerontologist, 50(4), 426–442. doi:10.1093/geront/gnq052
  • Castle, N.G., Hanlon, J.T., & Handler, S.M. (2009). Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. American Journal of Geriatric Pharamcotherapy, 7(3), 143–150.
  • Chen, Y., Briesacher, B.A., Field, T.S., Tjia, J., Lau, D.T., & Gurwitz, J.H. (2010). Unexplained variation across US nursing homes in antipsychotic prescribing rates. Archives of Internal Medicine, 170(1), 89–95. doi:10.1001/archinternmed.2009.469
  • Centers for Medicare and Medicaid (CMS). (2014). Nursing home compare quality measures. Retrieved from http://www.medicare.gov/NursingHomeCompare/Data/Long-Stay-Residents.html
  • Cohen-Mansfield, J. (2001). Nonpharmacological interventions for inappropriate behavior in dementia. The American Journal of Geriatric Psychiatry, 9(4), 361–381.
  • Cohen-Mansfield, J. (2003). Nonpharmacological interventions for persons with dementia. Alzheimer's Care Today, 6(2), 129–145. doi:10.1177/0891988703258665
  • Cohen-Mansfield, J., & Jensen, B. (2008). Physicians’ perceptions of their role in treating dementia-related behavior problems in the nursing home: Actual practice and the ideal. Journal of the American Medical Directors Association, 9(8), 552–557. doi:10.1016/j.jamda.2008.02.001
  • Cohen-Mansfield, J., Libin, A., & Marx, M.S. (2007). Nonpharmacological treatment of agitation: A controlled trial of systematic individualized intervention. Journal of Gerontology: Medical Sciences, 62A(8), 908–916.
  • Cohen-Mansfield, J., Taylor, L., & Werner, P. (1998). Delusions and hallucinations in an adult day care population: A longitudinal study. American Journal of Geriatric Psychiatry, 6(2), 104–121.
  • Cohen-Mansfield, J., Thein, K., Marx, M.S., & Dakheel-Ali, M. (2012). What are the barriers to performing nonpharmacological interventions for behavioral symptoms in the nursing home? Journal of the American Medical Directors Association, 13, 400–405. doi:10.1016/j/jamda.2011.07.006
  • Collier, E., & Harrington, C. (2008). Staffing characteristics, turnover rates, and quality of resident care in nursing facilities. Research in Gerontological Nursing, 1(3), 157–170. doi:10.3928/00220124-20091301-03
  • Cummings, J.L., Miller, B., Hill, M., & Neshkes, R. (1987). Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Archives of Neurology, 44(4), 389–393. doi:10.1001/archneur.1987.00520160031010
  • Dorsey, E., Rabbani, A., Gallagher, S.A., Conti, R.M., & Alexander, G. (2010). Impact of FDA black box advisory on antipsychotic medication use. Archives of Internal Medicine, 170(1), 96–103. doi:10.1001/archinternmed.2009.456
  • Grabowski, D.C., O’Malley, A.J., Afendulis, C.C., Caudry, D.J., Elliot, A., & Zimmerman, S. (2014). Culture change and nursing home quality of care. The Gerontologist, 54(S1), S35–D45. doi:10.1093/geront/gntl143
  • Harrington, C., Carrillo, H., Dowdell, M., Tang, P.T., & Blank, B.W. (2011). Nursing facilities, staffing, residents and facility deficiencies, 2005 through 2010. San Francisco, CA: Department of Social & Behavioral Sciences, University of California.
  • Harrington, C., Woolhandler, S., Mullan, J., Carrillo, H., & Himmelstein, D.U. (2001). Does investor ownership of nursing home compromise the quality of care? American Journal of Public Health, 91(9), 1452–1455. doi:10.2105/AJPH.91.9.1452
  • Hughes, C.M., & Lapane, K.L. (2005). Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes. Drugs and Aging, 22(4), 339–351. doi:1170-229X/05/0004-0339
  • Hughes, C.M., Lapane, K.L., & Mor, V. (2000). Influence of facility characteristics on use of antipsychotic medications in nursing homes. Medical Care, 38(12), 1164–1173.
  • Hurd, M.D., Martorell, P., Delavande, A., Mullen, K.J., & Langa, K.M. (2013). Monetary cost of dementia in the United States. New England Journal of Medicine, 368(14), 1326–1334. doi:10.1056/NEJMsa1204629
  • Kales, H.C., Zivin, K., Kim, H., Valenstein, M., Chiang, C., Ignacio, R., … Blow, L.C. (2011). Trends in antipsychotic use in dementia 1999-2007. Archives of General Psychiatry, 68(2), 190–197. doi:10.1001/archgenpsychiatry.2010.200
  • Kamble, P., Chen, H., Sherer, J., & Aparasu, R.R. (2008). Antipsychotic drug use among elderly nursing home residents in the United States. The American Journal of Geriatric Pharmacotherapy, 6(4), 187–197. doi:http://dx.doi.org/10.1016/j.amjopharm.2008.10.002
  • Kamble, P., Chen, H., Sherer, J.T., & Aparasu, R.R. (2009). Use of antipsychotics among elderly nursing home residents with dementia in the US: An analysis of national survey data. [A]. Drugs & Aging, 26(6), 483–492.
  • Karlin, B.E., Visnic, S., McGee, J.S., & Teri, L. (2014). Results from the multisite implementation of STAR-VA: A multicomponent psychosocial intervention for managing challenging dementia-related behaviors of veterans. Psychological Services, 11(2), 200–208. doi:10.1037/a0033683
  • Kontezka, R.T., Brauner, D.J., Shega, J., & Werner, R.M. (2014). The effects of public reporting on physical restraints and antipsychotic use in nursing home residents with severe cognitive impairment. Journal of the American Geriatrics Society, 62(3), 454–461. doi:10.1111/jps.12711
  • Koren, M.J. (2012). Person-centered care for nursing home residents: The culture-change movement. Health Affairs, 29, 312–317. doi:10.1377/hltaff.2009.0966
  • Lemay, C.A., Mazor, K.M., Field, T.S., Donovan, J., Kanaan, A., Briesacher, B.A., … Tija, J. (2013). Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff. JAMDA, 14, 895–900. doi:10.1016/j.jamda.2013.08.009
  • Lester, P., Kohen, I., Stefanacci, R.G., & Feuerman, M. (2011). Antipsychotic drug use since the FDA black box warning: Survey of nursing home policies. Journal of the American Medical Directors Association, 12(8), 573–577. Retrieved from http://dx.doi.org/10.1016/j.jamda.2010.04.005
  • Molinari, V., Chiriboga, D., Branch, L.G., Cho, S., Turner, K., Guo, J., & Hyer, K. (2010). Provision of psychopharmacological services in nursing homes. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 65B, 57–60. doi:10.1093/geronb/gbp080
  • Molinari, V., Chiriboga, D., Branch, L.G., Schinka, J., Schonfeld, L., Kos, L., … Hyer, K. (2011). Reasons for psychiatric prescription for new nursing home residents. Aging & Mental Health, 15(7), 904–912.
  • Mor, V., Zinn, J., Angelelli, J., Teno, J.M., & Miller, S.C. (2004). Drive to tiers: Socioeconomic and racial dispairities in the quality of nursing home care. The Milbank Quarterly, 82(2), 227–256. doi:10.1111/j.0887-378X.2004.00309.x
  • Mullaney, T. (2013). CMS and AHCA: Providers zeroing in on antipsychotic reduction target. Retrieved from http://www.mcknights.com/cms-and-ahca-providers-zeroing-in-on-antipsychotic-reduction-target/article/309128/
  • O’Neill, C., Harrington, C., Kitchener, M., & Saliba, D. (2003). Quality of care in nursing homes. Medical Care, 41(12), 1318–1330.
  • Omnibus Budget Reconciliation Act. (1987). P.L. 100–203. Subtitle C. Nursing Home Reform Act.
  • Plassman, B.L., Langa, K.M., Fisher, G.G., Heeringa, S.G., Weir, D.R., Ofstedal, M.B., … Wallace, R.B. (2007). Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology, 29, 125–132. doi:10.1159/000109998
  • Porsteinsson, A.P., Drye, L.T., Pollock, B.G., Devanand, D.P., Frangakis, C., Ismail, Z., … Jacobo, E. (2014). Effect of citalopram on agitation in Alzheimer's disease: The CitAD randomized clinical trial. JAMA, 311(7), 682–691. doi:10.1001/jama.2014.93
  • Rahman, A.N., & Schnelle, J.F. (2008). The nursing home culture change movement: Recent past, present, and future directions for research. The Gerontologist, 48(2), 142–148.
  • Rapp, M.A., Mell, T., Majic, T., Treusch, Y., Nordheim, J., Niemann-Mirmehdi, M., … Heinz, A. (2013). Agitation in nursing home residents with dementia (VIDEANT Trial): Effects of a cluster-randomized, controlled, guidelines implementation trail. Journal of the American Medical Directors Association, 14, 690–695. doi:10.1016/j.jamda.2013.05.017
  • Reisberg, B., Borenstein, J., Salob, S.P., & Ferris, S.H. (1987). Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. Journal of Clinical Psychiatry, 48(5), 9–15.
  • Schneider, L.S., Dagerman, K.S., & Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA, 294(15), 1934–1943. doi:10.1001/jama.294.15.1934
  • Schneider, L.S., Tariot, P.N., Dagerman, K.S., Davis, S.M., Hsiao, J.K., Ismail, M.S., … Stroup, T.S. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355(15), 1525–1538.
  • Seitz, D.P., Purandare, N., & Conn, D. (2010). Prevalence of psychiatric disorders among older adults in long-term care homes: A systematic review. International Psychogeriatrics, 27(7), 1025–1039. doi:10.1017/S1041610210000608
  • Shier, V., Khodyakov, D., Cohen, L.W., Zimmerman, S., & Saliba, D. (2014). What does the evidence really say about culture change in nursing homes? The Gerontologist, 54(S1), S6–S16. doi:10.1093/geront/gnt147
  • Tjia, J., Gurwitz, J.H., & Briesacher, B.A. (2012). Challenge of changing nursing home prescribing culture. The American Journal of Geriatric Pharmacotherapy, 10(1), 37–46. doi:10.1016/j.amjopharm.2011.12.005
  • Tritz, K., Laughman, M., & Bonner, A. (2014). Report on the CMS national partnership to improve dementia care in nursing homes: Q4 2011–Q1 2014. Retrieved from http://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter-14-19.pdf
  • Van Haitsma, K.S., Curyto, K., Abbot, K.M., Towsley, G.L., Spector, A., & Kleban, M. (2013). A randomized controlled trial for an individualized positive psychosocial intervention for the affective and behavioral symptoms of dementia in nursing home residents. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. doi:10.1093/geronb/gbt102
  • Vernooij-Dassen, M., Vasse, E., Zuidema, S., Cohen-Mansfield, J., & Moyle, W. (2010). Psychosocial interventions for dementia patients in long-term care. International Psychogeriatrics, 22(7), 1121–1128. doi:10.1017/S1041610210001365
  • Volicer, L. (2012). Antipsychotic do not have to be used ‘off label’ in dementia. Journal of the American Medical Directors Association, 13, 495–496. doi:10.1016/j.jamda.2014.04.006
  • Volicer, L., Frijters, D.H.M., & Van der Steen, J.T. (2011). Relationship between symptoms of depression and agitation in nursing home residents with dementia. International Journal of Geriatric Psychiatry, 27, 749–754. doi:10.1002/gps.2800
  • Zimmerman, S., Shier, V., & Saliba, D. (2014). Transforming nursing home culture: Evidence for practice and policy. The Gerontologist, 54(S1), S1–S5. doi:10.1093/geront/gnt161

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.